Skip to content
value.today

Alnara Pharmaceuticals Inc.

🇺🇸 Cambridge, Massachusetts, USAPharmaceuticalsFounded 2008
Total raised
$20 M
1 round on record
Latest round
$20 M
Jan 2010
First round on record
Jan 2010
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Alnara Pharmaceuticals Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2010$20 MNo. 1$10 to $50 million

Alnara Pharmaceuticals Inc.: Raise no. 1, Jan 2010

Investors in this round

9 investors had bought by the notice of Feb 4, 2010: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $35 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexey Margolin · Executive Officer, Director
  • Lee Brettman · Executive Officer
  • Robert Gallotto · Executive Officer
  • Ashley H. Dombkowski · Director
  • Christoph H. Westphal · Director
  • James N. Topper · Director
  • Richard H. Aldrich · Director
  • Robert H. Tepper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Alexey Margolin, President and Chief Executive Officer. Newest notice filed Feb 4, 2010. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Alnara Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2010).

    SEC Form D · Feb 2010

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Feb 2010

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Alnara Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Alnara Pharmaceuticals Inc.
NameRoleNamed in
Alexey MargolinExecutive officerFeb 2010
Lee BrettmanExecutive officerFeb 2010
Robert GallottoExecutive officerFeb 2010
Alexey MargolinDirectorFeb 2010
Ashley H. DombkowskiDirectorFeb 2010
Christoph H. WestphalDirectorFeb 2010
James N. TopperDirectorFeb 2010
Richard H. AldrichDirectorFeb 2010
Robert H. TepperDirectorFeb 2010